BackSage Therapeutics Overview

Sage Therapeutics Current Assets

Track Sage Therapeutics's current assets ($410M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$409.08M
40.44% YoYΔ $-277.73M vs prior year quarter

Peer trimmed avg / median

Loading

Sage Therapeutics Current Assets History

Loading

Sage Therapeutics vs. peers: Current Assets Comparison

Loading

Sage Therapeutics Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Sage Therapeutics (SAGE) FAQ

As of the most recent data (June 2025), SAGE shows a current assets of $410M. That compares with $690M in the prior-year period — down 40.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SAGE's current assets is now $410M (was $690M) — a 40.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Sage Therapeutics is outperforming or lagging.

Tracking SAGE's current assets over time shows whether Sage Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $410M That compares with $690M in the prior-year period — down 40.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Sage Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $410M) with ownership activity and broader fundamentals.

Sage Therapeutics's current assets is $410M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.